Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 4,5+160 mikrog/dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 4,5+160 mikrog/dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog/dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - budesonid, formoterolfumarat dihydrat - inhalationspulver - 4,5+160 mikrog/dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - beclometasondipropionat, formoterolfumarat dihydrat - inhalationsspray, opløsning - 100+6 mikrog./dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 4,5+160 mikrog/dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasondipropionat, formoterolfumarat dihydrat - inhalationspulver - 200+12 mikrog./dosis

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

astrazeneca a/s - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 2,25+80 mikrog/dosis

Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.